United States Biotechnology & Medical Research

Compass Pathways PLC (CMPS)

Track

The most recent insider trading activity occurred on September 26, 2024, with a significant sell transaction by ATAI Life Sciences N.V. valued at over $16 million. Prior to this, several planned sales were executed by insiders George Jay Goldsmith and Ekaterina Malievskaia in May 2024. The total volume of these planned sales was substantial.
Stock chart
Ticker: CMPS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
ATAI Life Sciences N.V.
1 sale — total 16,093,000 USD
Sale 26 Sep 2024
Value US$1,235,551.82 | Price 73.66 | Shares 9,266
Planned sale 21 May 2024
Value US$3,417,551.90 | Price 388.65 | Shares 80,674
Planned sale 21 May 2024
Value US$3,380,733.24 | Price 401.65 | Shares 68,061
Planned sale 21 May 2024
Value US$70,379.42 | Price 7.91 | Shares 8,900
Planned sale 21 May 2024
Value US$70,379.42 | Price 7.91 | Shares 8,900
Planned sale 21 May 2024
Value US$70,379.42 | Price 7.91 | Shares 8,900
Planned sale 21 May 2024
Value US$70,379.42 | Price 7.91 | Shares 8,900
Planned sale 20 May 2024
Value US$52,900.08 | Price 7.89 | Shares 6,703
Planned sale 20 May 2024
Value US$52,907.97 | Price 7.89 | Shares 6,704
Planned sale 20 May 2024
Value US$52,907.97 | Price 7.89 | Shares 6,704
Planned sale 20 May 2024
Value US$52,900.08 | Price 7.89 | Shares 6,703
Planned sale 3 May 2024
Value US$165,456.45 | Price 8.82 | Shares 18,762
Planned sale 3 May 2024
Value US$165,447.63 | Price 8.82 | Shares 18,761
Planned sale 3 May 2024
Value US$165,447.63 | Price 8.82 | Shares 18,761
Planned sale 3 May 2024
Value US$165,456.45 | Price 8.82 | Shares 18,762
Planned sale 2 May 2024
Value US$79,760.01 | Price 8.29 | Shares 9,621
Planned sale 2 May 2024
Value US$79,768.30 | Price 8.29 | Shares 9,622
Planned sale 2 May 2024
Value US$79,768.30 | Price 8.29 | Shares 9,622
Planned sale 2 May 2024
Value US$79,760.01 | Price 8.29 | Shares 9,621
Planned sale 17 Apr 2024
Value US$95,307.48 | Price 8.78 | Shares 10,850
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-27 2024-09-26 S Sale
ATAI Life Sciences N.V.
Large shareholder
9,266 +10.0%
73.66
US$1,235,552 		9,266 +10.0% 73.66 US$1,235,552
2024-05-22 2024-05-21 PlS Planned sale
Malievskaia Ekaterina
Large shareholder
80,674 +39.0%
388.65
US$3,417,552 		80,674 +39.0% 388.65 US$3,417,552
2024-05-22 2024-05-21 PlS Planned sale
Malievskaia Ekaterina
Large shareholder
68,061 +29.4%
401.65
US$3,380,733 		68,061 +29.4% 401.65 US$3,380,733
2024-05-22 2024-05-21 PlS Planned sale
Goldsmith George Jay
Large shareholder
8,900 -0.2%
7.91
US$70,379 		8,900 -0.2% 7.91 US$70,379
2024-05-22 2024-05-21 PlS Planned sale
Goldsmith George Jay
Large shareholder
8,900 -0.2%
7.91
US$70,379 		8,900 -0.2% 7.91 US$70,379
2024-05-22 2024-05-21 PlS Planned sale
Goldsmith George Jay
Large shareholder
8,900 -0.2%
7.91
US$70,379 		8,900 -0.2% 7.91 US$70,379
2024-05-22 2024-05-21 PlS Planned sale
Goldsmith George Jay
Large shareholder
8,900 -0.2%
7.91
US$70,379 		8,900 -0.2% 7.91 US$70,379
2024-05-22 2024-05-20 PlS Planned sale
Malievskaia Ekaterina
Large shareholder
6,703 -0.2%
7.89
US$52,900 		6,703 -0.2% 7.89 US$52,900
2024-05-22 2024-05-20 PlS Planned sale
Malievskaia Ekaterina
Large shareholder
6,704 -0.2%
7.89
US$52,908 		6,704 -0.2% 7.89 US$52,908
2024-05-22 2024-05-20 PlS Planned sale
Goldsmith George Jay
Large shareholder
6,704 -0.2%
7.89
US$52,908 		6,704 -0.2% 7.89 US$52,908
2024-05-22 2024-05-20 PlS Planned sale
Goldsmith George Jay
Large shareholder
6,703 -0.2%
7.89
US$52,900 		6,703 -0.2% 7.89 US$52,900
2024-05-06 2024-05-03 PlS Planned sale
Malievskaia Ekaterina
Large shareholder
18,762 -0.5%
8.82
US$165,456 		18,762 -0.5% 8.82 US$165,456
2024-05-06 2024-05-03 PlS Planned sale
Malievskaia Ekaterina
Large shareholder
18,761 -0.5%
8.82
US$165,448 		18,761 -0.5% 8.82 US$165,448
2024-05-06 2024-05-03 PlS Planned sale
Goldsmith George Jay
Large shareholder
18,761 -0.5%
8.82
US$165,448 		18,761 -0.5% 8.82 US$165,448
2024-05-06 2024-05-03 PlS Planned sale
Goldsmith George Jay
Large shareholder
18,762 -0.5%
8.82
US$165,456 		18,762 -0.5% 8.82 US$165,456
2024-05-06 2024-05-02 PlS Planned sale
Malievskaia Ekaterina
Large shareholder
9,621 -0.2%
8.29
US$79,760 		9,621 -0.2% 8.29 US$79,760
2024-05-06 2024-05-02 PlS Planned sale
Malievskaia Ekaterina
Large shareholder
9,622 -0.2%
8.29
US$79,768 		9,622 -0.2% 8.29 US$79,768
2024-05-06 2024-05-02 PlS Planned sale
Goldsmith George Jay
Large shareholder
9,622 -0.2%
8.29
US$79,768 		9,622 -0.2% 8.29 US$79,768
2024-05-06 2024-05-02 PlS Planned sale
Goldsmith George Jay
Large shareholder
9,621 -0.2%
8.29
US$79,760 		9,621 -0.2% 8.29 US$79,760
2024-04-18 2024-04-17 PlS Planned sale
Goldsmith George Jay
Large shareholder
10,850 -0.3%
8.78
US$95,307 		10,850 -0.3% 8.78 US$95,307
Explore more

More insider trading research around Compass Pathways PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America